As Alkermes seeks to catch up, it has provided the treatment in 40 correctional facilities in 18 states, offering free samples to many of them.
Two doctors told me Alkermes paid them to participate in focus-group panels where they were asked by company representatives about how to market the shot to criminal-justice officials.
The jail has provided samples of Aristada to 10 inmates but hasn’t accepted payments from drug companies, or perks such as free lunches.
More than half of those are ordered by judges, he said, but judges leave it up to doctors to decide which product is best for their patients.
While some jail officials see mostly an upside in drug companies’ marketing efforts, others say it’s more complicated.

Comments to: Marketing Psychiatric Drugs to Jailers and Judges

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.

Login

Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.